Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter D Arkwright

Showing results (71-80 of 170) with videos related to

Pageof 17
Sort By:
Journal of the American Academy of Dermatology|May 29, 2025
Efficacy and safety of dupilumab in pediatric patients aged 6 months to 11 years with erythrodermic atopic dermatitis: A post-hoc analysis of 3 clinical trialsAmy S Paller, Elaine C Siegfried, Michael J Cork, et al.
Journal of Asthma and Allergy|June 10, 2026
Dupilumab is Effective in Young Children with Atopic Dermatitis Regardless of Type 2 ComorbiditiesMark Boguniewicz, Lawrence D Sher, Amy S Paller, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 6, 2019
Life-threatening pulmonary interstitial lung disease complicating pediatric nonhumoral immunodeficienciesTariq Al Farsi, Stephen M Hughes, Robert F Wynn, et al.
Journal of Clinical Immunology|April 10, 2024
Omenn Syndrome in Two Infants with Different Hypomorphic Variants in Janus Kinase 3Christo Tsilifis, Jarmila Stremenova Spegarova, Ross Good, et al.
Frontiers in Immunology|April 9, 2020
Infant Alveolar Macrophages Are Unable to Effectively Contain <i>Mycobacterium tuberculosis</i>Anu Goenka, Ian E Prise, Emma Connolly, et al.
Frontiers in Immunology|September 2, 2017
14 Years after Discovery: Clinical Follow-up on 15 Patients with Inducible Co-Stimulator DeficiencyJohanna Schepp, Janet Chou, Andrea Skrabl-Baumgartner, et al.
Allergy|April 23, 2020
Type 2 immunity in the skin and lungsCezmi A Akdis, Peter D Arkwright, Marie-Charlotte Brüggen, et al.
Cell Research|September 23, 2009
Fas stimulation of T lymphocytes promotes rapid intercellular exchange of death signals via membrane nanotubesPeter D Arkwright, Francesca Luchetti, Julien Tour, et al.
Journal of the American Academy of Dermatology|September 30, 2024
The effect of dupilumab on caregiver- and patient-reported outcomes in young children with moderate-to-severe atopic dermatitis: Results from a placebo-controlled, phase 3 studyAmy S Paller, Jonathan I Silverberg, Eric L Simpson, et al.
Paediatric Drugs|January 24, 2024
Infections in Children Aged 6 Months to 5 Years Treated with Dupilumab in a Placebo-Controlled Clinical Trial of Moderate-to-Severe Atopic DermatitisAmy S Paller, Elaine C Siegfried, Michael J Cork, et al.
Pageof 17

Showing results (71-80 of 170) with videos related to

Sort By:
Pageof 17
Journal of the American Academy of Dermatology|May 29, 2025
Efficacy and safety of dupilumab in pediatric patients aged 6 months to 11 years with erythrodermic atopic dermatitis: A post-hoc analysis of 3 clinical trialsAmy S Paller, Elaine C Siegfried, Michael J Cork, et al.
Journal of Asthma and Allergy|June 10, 2026
Dupilumab is Effective in Young Children with Atopic Dermatitis Regardless of Type 2 ComorbiditiesMark Boguniewicz, Lawrence D Sher, Amy S Paller, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 6, 2019
Life-threatening pulmonary interstitial lung disease complicating pediatric nonhumoral immunodeficienciesTariq Al Farsi, Stephen M Hughes, Robert F Wynn, et al.
Journal of Clinical Immunology|April 10, 2024
Omenn Syndrome in Two Infants with Different Hypomorphic Variants in Janus Kinase 3Christo Tsilifis, Jarmila Stremenova Spegarova, Ross Good, et al.
Frontiers in Immunology|April 9, 2020
Infant Alveolar Macrophages Are Unable to Effectively Contain <i>Mycobacterium tuberculosis</i>Anu Goenka, Ian E Prise, Emma Connolly, et al.
Frontiers in Immunology|September 2, 2017
14 Years after Discovery: Clinical Follow-up on 15 Patients with Inducible Co-Stimulator DeficiencyJohanna Schepp, Janet Chou, Andrea Skrabl-Baumgartner, et al.
Allergy|April 23, 2020
Type 2 immunity in the skin and lungsCezmi A Akdis, Peter D Arkwright, Marie-Charlotte Brüggen, et al.
Cell Research|September 23, 2009
Fas stimulation of T lymphocytes promotes rapid intercellular exchange of death signals via membrane nanotubesPeter D Arkwright, Francesca Luchetti, Julien Tour, et al.
Journal of the American Academy of Dermatology|September 30, 2024
The effect of dupilumab on caregiver- and patient-reported outcomes in young children with moderate-to-severe atopic dermatitis: Results from a placebo-controlled, phase 3 studyAmy S Paller, Jonathan I Silverberg, Eric L Simpson, et al.
Paediatric Drugs|January 24, 2024
Infections in Children Aged 6 Months to 5 Years Treated with Dupilumab in a Placebo-Controlled Clinical Trial of Moderate-to-Severe Atopic DermatitisAmy S Paller, Elaine C Siegfried, Michael J Cork, et al.
Pageof 17